Showing results (491-500 of 867) with videos related to

Sort By:
Pageof 87
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Improving the efficiency of clinical trials in multiple sclerosisRuth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Clinical trials in multiple sclerosis: potential future trial designsNavid Manouchehri, Yinan Zhang, Amber Salter, et al.
Multiple Sclerosis and Related Disorders|May 27, 2025
The written symbol digit modalities test in multiple sclerosis is sensitive to cognitive and motor disabilityMatthew A Greenwald, Héctor G Cancel Asencio, Kevin Hu, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsYinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
American Journal of Health Promotion : AJHP|April 28, 2017
Results of a Randomized Trial on an Intervention Promoting Adoption of Occupational Sun Protection PoliciesDavid B Buller, Barbara J Walkosz, Mary Klein Buller, et al.
Journal of General Internal Medicine|December 22, 2004
A practical randomized trial to improve diabetes careRussell E Glasgow, Paul A Nutting, Diane K King, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosisDeborah M Miller, Richard A Rudick, Monika Baier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 20, 2026
Diminishing returns of disease-modifying treatment in older participants of MS clinical trialsEva Strijbis, Jop Mostert, Miguel D'Haeseleer, et al.
Cancer|October 13, 2005
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantationJacopo Peccatori, Lisbeth Barkholt, Tanner Demirer, et al.
Pageof 87